Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mature T-cell leukemias.

Farhad Ravandi1, Hagop Kantarjian, Dan Jones

  • 1Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. fravandi@mdanderson.org

Cancer
|September 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlates of mobile device use in young children: a systematic review and meta-analysis.

BMJ public health·2026
Same author

Role of professional associations in the drive for policy change and uptake of new WHO recommendations for the prevention and treatment of postpartum hemorrhage.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Same author

Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

Blood·2026
Same author

Multicenter study comparing outcomes of robotic versus video-assisted thoracoscopic resection of non-small cell lung cancer following neoadjuvant chemoimmunotherapy.

Journal of robotic surgery·2026
Same author

Elective Use of Veno-Venous Extracorporeal Membrane Oxygenation to Support Complex Surgery Involving the Central Airways.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

Robotic-Assisted Single-Port Subcostal Entry Technique: The Cornell Method.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
Same journal

Maintenance therapy in gynecologic malignancies: Current and future state.

Cancer·2026
Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026
Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026
Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026
See all related articles

Mature T-cell and NK-cell leukemias are rare lymphoid malignancies. Advances in immunophenotypic and molecular tools improve diagnosis and understanding of their pathogenesis, guiding new therapeutic strategies.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Mature T-cell and Natural Killer (NK)-cell leukemias are uncommon lymphoid neoplasms.
  • These disorders represent a small fraction of all lymphoid malignancies.

Purpose of the Study:

  • To review the clinical and pathological features of mature T-cell leukemias.
  • To highlight recent advancements in distinguishing these from B-cell malignancies.
  • To discuss insights into pathogenesis and emerging therapeutic strategies.

Main Methods:

  • Utilizing modern immunophenotypic and molecular tools for disease classification.
  • Identifying recurrent cytogenetic abnormalities.
  • Analyzing molecular events influencing cellular signaling pathways.

Related Experiment Videos

Main Results:

  • Improved distinction between T-cell/NK-cell leukemias and B-cell counterparts.
  • Enhanced understanding of the pathogenesis of these leukemias.
  • Identification of novel therapeutic targets and agents, such as alemtuzumab.

Conclusions:

  • Recent advancements have significantly improved the understanding and diagnosis of mature T-cell and NK-cell leukemias.
  • Targeted therapies are showing promise for these challenging hematologic malignancies.